Home / Sweden / CellaVision AB
CellaVision AB
Short position disclosed on July 30, 2026.
0.59% of the capital sold short
1 disclosing funds
12 disclosures on record
SE0000683484 ISIN code
Evolution of the disclosed total
0%0.2%0.4%0.6%
Oct 2025Jan 2026Apr 2026Jul 2026
July 4, 2019 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Citadel Advisors LLC | 0.59% | new | July 30, 2026 |
On the other side: the funds that hold CellaVision AB Titelia
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| July 30, 2026 | Citadel Advisors LLC | 0.59% | still open |
| June 26, 2026 | Citadel Advisors LLC | 0.60% | still open |
| June 15, 2026 | Citadel Advisors LLC | 0.50% | still open |
| December 17, 2019 | Bodenholm Capital AB | 0.00% | still open |
| September 27, 2019 | Keel Capital S.A., Sicav-Sif – Foghorn X2 | 0.00% | still open |
| September 2, 2019 | Bodenholm Capital AB | 0.53% | still open |
| September 1, 2019 | Bodenholm Capital AB | 0.53% | still open |
| August 15, 2019 | Keel Capital S.A., Sicav-Sif – Foghorn X2 | 0.50% | still open |
| August 14, 2019 | Keel Capital S.A., Sicav-Sif – Foghorn X2 | 0.50% | still open |
| August 1, 2019 | Keel Capital S.A., Sicav-Sif – Foghorn X2 | 0.00% | still open |
| July 5, 2019 | Keel Capital S.A., Sicav-Sif – Foghorn X2 | 0.51% | still open |
| July 4, 2019 | Keel Capital S.A., Sicav-Sif – Foghorn X2 | 0.51% | still open |
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 12.26% of the capital sold short
- Elekta AB (publ) 9.63% of the capital sold short
- JM AB 7.01% of the capital sold short
- Hemnet Group AB (publ) 6.08% of the capital sold short
- Embracer Group AB 5.75% of the capital sold short
- Bonesupport Holding AB 5.67% of the capital sold short
- Truecaller AB 5.43% of the capital sold short
- Xvivo Perfusion Aktiebolag 4.91% of the capital sold short
- Tobii AB 4.34% of the capital sold short
- RaySearch Laboratories AB (publ) 4.16% of the capital sold short
- Dynavox Group AB 3.80% of the capital sold short
- Svenska Cellulosa Aktiebolaget SCA 3.77% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, CellaVision AB, source Finansinspektionen, data as at July 30, 2026, https://www.quivad.com/action/cellavision-ab